Hospira unveils plans to acquire injectable company
Hospital products giant Hospira Inc., based in Lake Forrest, Ill., announced that it will acquire Australia?s Mayne Pharma Limited for $2 billion.
Hospital products giant Hospira Inc., based in Lake Forrest, Ill., announced that it will acquire Australia’s Mayne Pharma Limited for $2 billion. Executives on both sides believe that the Hospira/Mayne combo will be a good fit strategically and establish Hospira as the worldwide leader in generic injectable pharmaceuticals. Mayne Pharma is a market leader in Europe and Australia and has a significant presence in Canada. Hospira expects the alliance to strengthen its global reach. Hospira, the hospital products division of Abbott Laboratories, is a global specialty pharmaceutical and medication delivery company.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
